| UniProt ID | QSOX2_HUMAN | |
|---|---|---|
| UniProt AC | Q6ZRP7 | |
| Protein Name | Sulfhydryl oxidase 2 | |
| Gene Name | QSOX2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 698 | |
| Subcellular Localization |
Membrane Single-pass membrane protein . Secreted . Cell membrane Single-pass membrane protein . Nucleus membrane Single-pass membrane protein . Seems to be predominantly targeted to the nuclear and outer plasma membrane. |
|
| Protein Description | Catalyzes the oxidation of sulfhydryl groups in peptide and protein thiols to disulfides with the reduction of oxygen to hydrogen peroxide. May contribute to disulfide bond formation in a variety of secreted proteins. Also seems to play a role in regulating the sensitization of neuroblastoma cells for interferon-gamma-induced apoptosis.. | |
| Protein Sequence | MAAAGAAVARSPGIGAGPALRARRSPPPRAARLPRLLVLLAAAAVGPGAGGAARLYRAGEDAVWVLDSGSVRGATANSSAAWLVQFYSSWCGHCIGYAPTWRALAGDVRDWASAIRVAALDCMEEKNQAVCHDYDIHFYPTFRYFKAFTKEFTTGENFKGPDRELRTVRQTMIDFLQNHTEGSRPPACPRLDPIQPSDVLSLLDNRGSHYVAIVFESNSSYLGREVILDLIPYESIVVTRALDGDKAFLEKLGVSSVPSCYLIYPNGSHGLINVVKPLRAFFSSYLKSLPDVRKKSLPLPEKPHKEENSEIVVWREFDKSKLYTVDLESGLHYLLRVELAAHKSLAGAELKTLKDFVTVLAKLFPGRPPVKKLLEMLQEWLASLPLDRIPYNAVLDLVNNKMRISGIFLTNHIKWVGCQGSRSELRGYPCSLWKLFHTLTVEASTHPDALVGTGFEDDPQAVLQTMRRYVHTFFGCKECGEHFEEMAKESMDSVKTPDQAILWLWKKHNMVNGRLAGHLSEDPRFPKLQWPTPDLCPACHEEIKGLASWDEGHVLTFLKQHYGRDNLLDTYSADQGDSSEGGTLARGEEEEKRLTPPEVSHGDRDTQSVRPPGALGPRPALPESLHHSLDGKLQSLDGPGAHKEVGGAAPFLGVDFSSLDMSLCVVLYVASSLFLMVMYFFFRVRSRRWKVKHHHPAV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 11 | Phosphorylation | AGAAVARSPGIGAGP CCCCHHCCCCCCCCH | 20.10 | 27251275 | |
| 25 | Phosphorylation | PALRARRSPPPRAAR HHHHHCCCCCCHHHH | 35.88 | 30266825 | |
| 70 | Phosphorylation | VWVLDSGSVRGATAN EEEECCCCCCCCCCC | 16.76 | 30387612 | |
| 77 | N-linked_Glycosylation | SVRGATANSSAAWLV CCCCCCCCCHHHHHH | 31.94 | UniProtKB CARBOHYD | |
| 109 | Methylation | RALAGDVRDWASAIR HHHHHCHHHHHHHHH | 38.19 | 115489797 | |
| 141 | O-linked_Glycosylation | YDIHFYPTFRYFKAF CEECCCCCHHHHHHH | 14.90 | OGP | |
| 146 | Ubiquitination | YPTFRYFKAFTKEFT CCCHHHHHHHHCCCC | 33.39 | - | |
| 149 | O-linked_Glycosylation | FRYFKAFTKEFTTGE HHHHHHHHCCCCCCC | 34.23 | 55832001 | |
| 153 | O-linked_Glycosylation | KAFTKEFTTGENFKG HHHHCCCCCCCCCCC | 34.68 | 55826353 | |
| 154 | O-linked_Glycosylation | AFTKEFTTGENFKGP HHHCCCCCCCCCCCC | 48.06 | 55826359 | |
| 159 | Ubiquitination | FTTGENFKGPDRELR CCCCCCCCCCCHHHH | 79.64 | 29967540 | |
| 178 | N-linked_Glycosylation | TMIDFLQNHTEGSRP HHHHHHHHCCCCCCC | 46.31 | UniProtKB CARBOHYD | |
| 183 | O-linked_Glycosylation | LQNHTEGSRPPACPR HHHCCCCCCCCCCCC | 35.07 | OGP | |
| 197 | O-linked_Glycosylation | RLDPIQPSDVLSLLD CCCCCCHHHHHHHHC | 24.79 | OGP | |
| 197 | Phosphorylation | RLDPIQPSDVLSLLD CCCCCCHHHHHHHHC | 24.79 | 20068231 | |
| 201 | Phosphorylation | IQPSDVLSLLDNRGS CCHHHHHHHHCCCCC | 27.08 | 20068231 | |
| 208 | Phosphorylation | SLLDNRGSHYVAIVF HHHCCCCCCEEEEEE | 14.38 | 25907765 | |
| 210 | Phosphorylation | LDNRGSHYVAIVFES HCCCCCCEEEEEEEC | 8.02 | 25907765 | |
| 217 | Phosphorylation | YVAIVFESNSSYLGR EEEEEEECCCCCCCC | 30.46 | 25907765 | |
| 218 | N-linked_Glycosylation | VAIVFESNSSYLGRE EEEEEECCCCCCCCE | 27.98 | UniProtKB CARBOHYD | |
| 219 | Phosphorylation | AIVFESNSSYLGREV EEEEECCCCCCCCEE | 29.64 | 25907765 | |
| 220 | Phosphorylation | IVFESNSSYLGREVI EEEECCCCCCCCEEH | 28.73 | 25907765 | |
| 221 | Phosphorylation | VFESNSSYLGREVIL EEECCCCCCCCEEHH | 17.01 | 25907765 | |
| 246 | Ubiquitination | TRALDGDKAFLEKLG EEECCCCHHHHHHHC | 46.71 | - | |
| 246 | 2-Hydroxyisobutyrylation | TRALDGDKAFLEKLG EEECCCCHHHHHHHC | 46.71 | - | |
| 266 | N-linked_Glycosylation | SCYLIYPNGSHGLIN EEEEECCCCCCCCHH | 47.86 | UniProtKB CARBOHYD | |
| 296 | Phosphorylation | LPDVRKKSLPLPEKP CCCHHHHCCCCCCCC | 37.95 | 21406692 | |
| 323 | Phosphorylation | EFDKSKLYTVDLESG ECCCCCCEEEECCCH | 14.41 | - | |
| 324 | Phosphorylation | FDKSKLYTVDLESGL CCCCCCEEEECCCHH | 20.27 | - | |
| 358 | Phosphorylation | KTLKDFVTVLAKLFP HHHHHHHHHHHHHCC | 15.14 | 20068231 | |
| 445 | O-linked_Glycosylation | TLTVEASTHPDALVG EEEECCCCCCCCCCC | 44.46 | OGP | |
| 453 | O-linked_Glycosylation | HPDALVGTGFEDDPQ CCCCCCCCCCCCCHH | 31.08 | OGP | |
| 465 | Phosphorylation | DPQAVLQTMRRYVHT CHHHHHHHHHHHHHH | 14.42 | 24719451 | |
| 520 | Phosphorylation | GRLAGHLSEDPRFPK CCCCCCCCCCCCCCC | 33.99 | 29978859 | |
| 520 | O-linked_Glycosylation | GRLAGHLSEDPRFPK CCCCCCCCCCCCCCC | 33.99 | OGP | |
| 532 | Phosphorylation | FPKLQWPTPDLCPAC CCCCCCCCCCCCHHH | 26.86 | 25690035 | |
| 562 | Phosphorylation | LTFLKQHYGRDNLLD HHHHHHHHCCCCCCC | 16.03 | 21406692 | |
| 570 | Phosphorylation | GRDNLLDTYSADQGD CCCCCCCCEECCCCC | 21.24 | 23403867 | |
| 571 | Phosphorylation | RDNLLDTYSADQGDS CCCCCCCEECCCCCC | 11.09 | 23403867 | |
| 572 | Phosphorylation | DNLLDTYSADQGDSS CCCCCCEECCCCCCC | 27.71 | 30266825 | |
| 578 | Phosphorylation | YSADQGDSSEGGTLA EECCCCCCCCCCCCC | 36.79 | 22167270 | |
| 579 | Phosphorylation | SADQGDSSEGGTLAR ECCCCCCCCCCCCCC | 45.03 | 25463755 | |
| 579 | O-linked_Glycosylation | SADQGDSSEGGTLAR ECCCCCCCCCCCCCC | 45.03 | OGP | |
| 583 | Phosphorylation | GDSSEGGTLARGEEE CCCCCCCCCCCCHHH | 28.27 | 30266825 | |
| 595 | O-linked_Glycosylation | EEEEKRLTPPEVSHG HHHHHCCCCCCCCCC | 40.61 | OGP | |
| 600 | O-linked_Glycosylation | RLTPPEVSHGDRDTQ CCCCCCCCCCCCCCC | 21.79 | OGP | |
| 608 | O-linked_Glycosylation | HGDRDTQSVRPPGAL CCCCCCCCCCCCCCC | 23.37 | OGP | |
| 624 | O-linked_Glycosylation | PRPALPESLHHSLDG CCCCCCHHHHHHCCC | 30.94 | OGP | |
| 635 | O-linked_Glycosylation | SLDGKLQSLDGPGAH HCCCCCCCCCCCCCC | 38.57 | 55832717 | |
| 657 | Phosphorylation | PFLGVDFSSLDMSLC CCCCCCHHHCCHHHH | 26.06 | 27251275 | |
| 658 | Phosphorylation | FLGVDFSSLDMSLCV CCCCCHHHCCHHHHH | 28.51 | 27251275 | |
| 662 | Phosphorylation | DFSSLDMSLCVVLYV CHHHCCHHHHHHHHH | 20.48 | 27251275 | |
| 668 | Phosphorylation | MSLCVVLYVASSLFL HHHHHHHHHHHHHHH | 5.16 | 27251275 | |
| 672 | Phosphorylation | VVLYVASSLFLMVMY HHHHHHHHHHHHHHH | 17.25 | 27251275 | |
| 679 | Phosphorylation | SLFLMVMYFFFRVRS HHHHHHHHHHHHHHH | 5.94 | 27251275 | |
| 692 | Ubiquitination | RSRRWKVKHHHPAV- HHHCCCCCCCCCCC- | 33.23 | 33845483 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of QSOX2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of QSOX2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of QSOX2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| NP1L1_HUMAN | NAP1L1 | physical | 26496610 | |
| SNF5_HUMAN | SMARCB1 | physical | 26496610 | |
| TTC1_HUMAN | TTC1 | physical | 26496610 | |
| C2CD5_HUMAN | C2CD5 | physical | 26496610 | |
| CEPT1_HUMAN | CEPT1 | physical | 26496610 | |
| NBEL2_HUMAN | NBEAL2 | physical | 26496610 | |
| ORC3_HUMAN | ORC3 | physical | 26496610 | |
| XRN1_HUMAN | XRN1 | physical | 26496610 | |
| IMPCT_HUMAN | IMPACT | physical | 26496610 | |
| TUT7_HUMAN | ZCCHC6 | physical | 26496610 | |
| CEP44_HUMAN | CEP44 | physical | 26496610 | |
| FBX30_HUMAN | FBXO30 | physical | 26496610 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-578, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-578, AND MASSSPECTROMETRY. | |